These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8744649)

  • 21. Immunosuppressive protocol with delayed use of low-dose tacrolimus after aortic transplantation suppresses donor-specific anti-MHC class I and class II antibody production in rats.
    Matia I; Fellmer P; Splith K; Varga M; Adamec M; Kämmerer I; Feldbrügge L; Krenzien F; Hau HM; Atanasov G; Schmelzle M; Jonas S
    Ann Transplant; 2014 May; 19():225-32. PubMed ID: 24815872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of 15-deoxyspergualin on MHC class I and II antigen expression following small bowel transplantation in rats.
    Fändrich F; Waaga AM; Jacob S; Schröder J; Schweizer E; Schroeder P
    Transplant Proc; 1994 Jun; 26(3):1592-3. PubMed ID: 8030051
    [No Abstract]   [Full Text] [Related]  

  • 23. Rapamycin graft pretreatment in small bowel and kidney transplantation in the rat.
    Chen H; Xu D; Qi S; Wu J; Luo H; Daloze P
    Transplantation; 1995 Apr; 59(8):1084-9. PubMed ID: 7732551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral donor leukocytes prolong survival of rat renal allografts.
    Noris M; Azzollini N; Mister M; Pezzotta A; Piccinini G; Casiraghi F; Cugini D; Perico N; Orisio S; Remuzzi G
    Kidney Int; 1999 Sep; 56(3):1101-12. PubMed ID: 10469380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplant surgery injury recruits recipient MHC class II-positive leukocytes into the kidney.
    Penfield JG; Wang Y; Li S; Kielar MA; Sicher SC; Jeyarajah DR; Lu CY
    Kidney Int; 1999 Nov; 56(5):1759-69. PubMed ID: 10571784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
    Koch U; Choksi S; Marcucci L; Korngold R
    J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of prolonged monoclonal antibody administration on cardiac allograft survival in the rat.
    Roza AM; Kimura H; Markmann J; Naji A
    Scand J Immunol; 1989 Sep; 30(3):333-8. PubMed ID: 2675304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significant enhancement by anti-ICOS antibody of suboptimal tacrolimus immunosuppression in rat liver transplantation.
    Guo L; Li XK; Enosawa S; Funeshima N; Suzuki S; Kimura H; Sugawara Y; Tezuka K; Makuuchi M
    Liver Transpl; 2004 Jun; 10(6):743-7. PubMed ID: 15162468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indirect T cell allorecognition: a cyclosporin A resistant pathway for T cell help for antibody production to donor MHC antigens.
    Sawyer GJ; Dalchau R; Fabre JW
    Transpl Immunol; 1993; 1(1):77-81. PubMed ID: 8081765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graft persistence effectively induces and maintains donor-specific unresponsiveness.
    Nishinaka H; Nakafusa Y; Hirano T; Takeda K; Kawano R; Nakano M; Arima T; Nakamura K; Kamei T; Tanaka M
    J Surg Res; 1997 Mar; 68(2):145-52. PubMed ID: 9184673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for processing of WAG antigens by the RT1-D class II MHC molecules of PVG rats during kidney allograft rejection.
    Priestley CA; Spencer SS; Sawyer GJ; Fabre JW
    Transplant Proc; 1990 Aug; 22(4):1947-8. PubMed ID: 2389491
    [No Abstract]   [Full Text] [Related]  

  • 32. Pancreas-graft immunogenicity and pretreatment with anti-class II monoclonal antibodies.
    Lloyd DM; Cotler SJ; Letai AG; Stuart FP; Thistlethwaite JR
    Diabetes; 1989 Jan; 38 Suppl 1():104-8. PubMed ID: 2642828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged survival of rat hepatic allografts pretreated with a single donor-specific blood transfusion: the distribution of donor cells expressing class I major histocompatibility complex antigens in the recipient.
    Yamaguchi Y; Goto M; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Miyanari N; Mori K; Ogawa M
    J Surg Res; 1996 Feb; 61(1):23-9. PubMed ID: 8769937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue distribution of MHC class II--positive cells, their down-manipulation by monoclonal antibodies and potential role in organ allograft immunogenicity.
    Krzymański M; Müller-Ruchholtz W
    Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):177-81. PubMed ID: 1300981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local inhibition of major histocompatibility complex class II induction within the graft: an effective way to induce immunosuppression.
    Ruers TJ; Buurman WA; van der Linden CJ; Kootstra G
    Transplant Proc; 1987 Feb; 19(1 Pt 1):246-7. PubMed ID: 3152698
    [No Abstract]   [Full Text] [Related]  

  • 36. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: in situ splenic distribution of donor class I major histocompatibility complex antigen-positive cells in the recipient.
    Goto M; Yamaguchi Y; Matsuno K; Takata N; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Miyanari N; Mori K; Ogawa M
    J Surg Res; 1996 Jan; 60(1):216-23. PubMed ID: 8592417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pretreatment of rat pancreatic islets with MHC I-A monoclonal antibody: in-vitro and in-vivo effects on islet antigenicity.
    Flesch BK; Bretzel RG; Otto DA; Ernst-Schlegel M; Federlin K
    Horm Metab Res; 1991 Aug; 23(8):357-61. PubMed ID: 1794836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
    Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
    Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.